Chloramphenicol + HydrocortisoneThird Party Manufacturing in India

Chloramphenicol + Hydrocortisone works by combining a broad-spectrum antibiotic mechanism with a potent anti-inflammatory pathway. Chloramphenicol suppresses bacterial protein synthesis by targeting the 50S ribosome, while hydrocortisone decreases inflammatory mediators and capillary permeability to help the body resolve swelling and infection concurrently. Unlike standalone anti-infective formulations, it addresses the symptomatic distress of inflammation alongside the root microbial cause. It is highly effective and well-tolerated for short-term application.

Therapeutic Uses

• Inflammatory Ocular Conditions: Indicated for managing responsive ocular inflammation where secondary bacterial infection risks or presence co-exist.
• Allergic Conjunctivitis: Prescribed when severe bacterial complications accompany allergic eye manifestations.

Why Manufacturers Choose Chloramphenicol + Hydrocortisone

Chloramphenicol + Hydrocortisone third party manufacturing in India is a major segment within premium ophthalmic prescription spaces due to its rapid clinical efficacy. Combining a classic antimicrobial like CAS 56-75-7 with a mild steroid allows brands to provide a comprehensive, multi-action remedy. Celesta Healthcare facilitates operations via production facilities that are WHO-GMP certified, ensuring accurate particle micronization to prevent corneal irritation. Utilizing these WHO-GMP approved channels allows brand owners to secure market share in highly competitive healthcare environments.